共 50 条
- [1] Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study [J]. FRONTIERS IN ONCOLOGY, 2020, 10
- [3] Risk-Adapted Postmastectomy Radiation Therapy for pT1-2N1M0 Breast Cancer: A Single Institution Study [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E29 - E29
- [6] Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer [J]. FRONTIERS IN ONCOLOGY, 2023, 13
- [8] High-Risk pT1-2N0 Breast Cancer may Benefit from Postmastectomy Radiotherapy: A Risk Stratification Analysis Based on Nomogram [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E17 - E17
- [9] Development and External Validation of a Nomogram to Predict the Benefit of Regional Node Irradiation in Patients with pT1-2N1M0 Breast Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E23 - E24
- [10] Risk-Adapted Postmastectomy Radiation Therapy for Patients with Clinical T1-2N0-1 Breast Cancer after Neoadjuvant Chemotherapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E595 - E596